Evidence map›Paper›PMID 35386616›Full record

ArticleExperimental and therapeutic medicine2022

First documented case of Myhre syndrome in Romania: A case report.

Andreea Cătană, Ruxandra Simonescu-Colan, Zina Cuzmici-Barabaș, Diana Militaru, Irina Iordănescu, Mariela Sanda Militaru

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Andreea CătanăDepartment of Oncogenetics, Institute of Oncology I. Chiricuță, 4000015 Cluj-Napoca, Romania.
Ruxandra Simonescu-ColanDepartment of Oncogenetics, Institute of Oncology I. Chiricuță, 4000015 Cluj-Napoca, Romania.
Zina Cuzmici-BarabașDepartment of Molecular Sciences, University of Medicine and Pharmacy, 4000012 Cluj-Napoca, Romania.
Diana MilitaruDepartment of Molecular Sciences, University of Medicine and Pharmacy, 4000012 Cluj-Napoca, Romania.
Irina IordănescuDepartment of Medical Genetics, Genetic Center Laboratory, Regina Maria, 011376 Bucharest, Romania.
Mariela Sanda MilitaruDepartment of Molecular Sciences, University of Medicine and Pharmacy, 4000012 Cluj-Napoca, Romania.
University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca · ROInstitute of Oncology Prof. Dr. Ion Chiricuta · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myhre syndrome is a rare genetic autosomal dominant connective tissue disorder, characterized by developmental delay, characteristic facial features, various bone and joint abnormalities, distinctive cardiovascular, ophthalmological and ear, nose and throat (ENT) manifestations, in association with mild to moderate intellectual disability and autism or autism spectrum disorder-like behaviour. The diagnosis of Myhre syndrome is established corroborating the clinical findings with

Indexed as

allergic manifestationsearMyhre syndromenose and throat infectionsSMAD4 genewhole-exome sequencing

Identifiers

PMID35386616
PMCPMC8972842
OpenAlexW4220655922

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.